-
Share
11,696 Posts.
1684
14/12/15
19:28
Share
Of all of the biotech's I hold - vla has the most cash in the bank. And now they go and raise another $30m!
And this is straight after the tax refund - which more than covered the whole of last quarter's spend.
However, I much prefer to have a biotech with too much money in the bank than not enough. That's always a disaster.
It also strengthens vla's bargaining position during a deal or takeover.
Cheers
-